Towards Healthcare

News

Your Daily Gateway to Essential News in Healthcare, Science, Technology and Business Worldwide

Freya’s rebrand indicates a new, promising era in the Women’s Healthcare Innovation
03 December 2025

Freya’s rebrand indicates a new, promising era in the Women’s Healthcare Innovation

Announcement Where Freya Pharma Solutions itself has been a promising pharmaceutical company expert in innovative therapies for women suffering from Female Sexual Disorders (FSD), its rebrand announcement is the same, promising, with a level-up. The Freya Phar, a solutions has been renamed to Arle...

Konica Minolta's new DR systems ramp at RSNA 2025
03 December 2025

Konica Minolta's new DR systems ramp at RSNA 2025

Announcement Konica Minolta Healthcare Americas, Inc., a known healthcare IT solutions and medical diagnostic imaging provider, proudly introduced its new KDR FMT and KDR FMT+ digital radiography (DR) systems at the Annual Meeting of the Radiological Society of North America (RSNA) 2025. These new...

The US’s first business and tech move after the Trump administration's tension
03 December 2025

The US’s first business and tech move after the Trump administration's tension

Announcement The U.S. State Department awarded Zipline a $150 million financial reward, a huge boost over three years. Zipline, a leading American autonomous and drone-delivery company, demonstrated its dedication and potential through its performance and reliability. The largest drone delivery se...

Crux steals the limelight with its finance and business strategy
02 December 2025

Crux steals the limelight with its finance and business strategy

Announcement Crux, the first ever benefits platform, has entered into its revolutionary phase with a back-to-back incredible startegies. Crux, the commendable partner to the giant pharma and suitable employers regardless of size, extending affordable and visible access to transitional quality of l...

Gan & Lee’s new blockbuster GRADUAL-3 Clinical Study to fix weight management
02 December 2025

Gan & Lee’s new blockbuster GRADUAL-3 Clinical Study to fix weight management

Announcement Gan & Lee Pharmaceuticals is now entering its third large-scale phase 3 clinical study, GRADUAL-3, of its glucagon-like peptide-1 receptor agonist (GLP-1 RA) bofanglutide injection in the adult population with overweight or obesity. This study will be covering bofanglutide injecti...

SK’s partnership strategy to acquire R&D and other rights
02 December 2025

SK’s partnership strategy to acquire R&D and other rights

Announcement SK Biopharmaceuticals, CO., Ltd, a leading biotech company pioneering in commercialisation, development and research of oncology and central nervous system (CNS) treatments, have declared its license partnership deal with the Wisconsin Alumni Research Foundation (WARF) to further obtai...

Tencent and Fangzhou’s AI solution package for Chronic-Disease Management
02 December 2025

Tencent and Fangzhou’s AI solution package for Chronic-Disease Management

Announcement Fangzhou Inc., a popular AI-empowered Internet healthcare solutions provider and Tencen Healthcare together introduced a robust ‘AI+Chronic Disease Management’ solution for smart understanding and capturing precision at the tech level. This is a crucial step and a sign of ...

GE Healthcare’s Pristina Recon DL received official rights to promote clear image quality
01 December 2025

GE Healthcare’s Pristina Recon DL received official rights to promote clear image quality

Announcement GE Healthcare proudly confirmed that it has earned the FDA Premarket Authorisation for its modern 3D mammography image reconstruction technology, Pristina Recon DL. This commendable technology is sponsored by deep learning, setting a high standard bar in image clarity and definition. ...

Hemostemix plans to kickstart its first two Cardiology Practices via an acquisition strategy
01 December 2025

Hemostemix plans to kickstart its first two Cardiology Practices via an acquisition strategy

Announcement Hemostemix Inc. is delighted to read out the bond letter of its plant for beginning with the first two cardiology practices via acquisition strategy, inspired by the Company’s intelligent commercialisation strategy and clinic roll-up. The intense practices of Dr Hector Rosario F...

TempraMed to tie into the commercial partnership with Israel’s known CFonsumer Health Distributor
01 December 2025

TempraMed to tie into the commercial partnership with Israel’s known CFonsumer Health Distributor

Announcement TempraMed Technologies Ltd., a Canada-based leading company, has entered a particular exclusive commercial distribution partnership with Guri A.A.O. to sell and promote (market) TempraMed’s full product line throughout the Israeli retail market. This partnership deal represents ...